Structura letalității prin recidiva tuberculozei pulmonare.

Haidarlî Ion; Tudor Elena; Alexandru Sofia; Râvneac Lilia; Bolotnicova Valentina; Cula Eugenia; Guțu-Grecu Mariana; Marusceac Irina

Conţinutul numărului revistei

Articolul precedent

Articolul urmator

478

Ultima descărcare din IBN:
2024-02-16 13:59

Căutarea după subiecte
similare conform CZU

616.24-002.5/312.2 (1)

Patologia sistemului respirator. Tulburări ale organelor de respiraţie (777)

SM ISO690:2012

HAIDARLÎ, Ion, TUDOR, Elena, ALEXANDRU, Sofia, RÂVNEAC, Lilia, BOLOTNICOVA, Valentina, CULA, Eugenia, GUȚU-GRECU, Mariana, MARUSCEAC, Irina. Structura letalității prin recidiva tuberculozei pulmonare.. In: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale, 2021, nr. 1(69), pp. 15-20. ISSN 1857-0011. DOI: https://doi.org/10.52692/1857-0011.2021.1-69.02

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale

Numărul 1(69) / 2021 / ISSN 1857-0011

Structura letalității prin recidiva tuberculozei pulmonare.

Characteristics of deaths by recurrence of lung tuberculosis.

Структура летальности от рецидива туберкулеза легких

DOI:https://doi.org/10.52692/1857-0011.2021.1-69.02

CZU: 616.24-002.5/312.2

Pag. 15-20

Haidarlî Ion, Tudor Elena, Alexandru Sofia, Râvneac Lilia, Bolotnicova Valentina, Cula Eugenia, Guțu-Grecu Mariana, Marusceac Irina

IMSP Institutul de Ftiziopneumologie „Chiril Draganiuc“

Disponibil în IBN: 31 mai 2021

Descarcă PDF

Rezumat

Din datele existente privind mortalitatea prin tuberculoza pulmonară recidivată s-au analizat anumite particularităţ i ale acesteia în perioada 2015-2017. Astfel, mortalitatea prin tuberculoza recidivată şi complicaţiile ei, a сonstituit 1,26%000 în 2015, 1,38%000 în 2016 şi 1,42%000 în 2017. Mortalitatea determinată de localizarea respiratorie a tuberculozei este mult mai înaltă (99,6%) decât cea cauzată de localizările extrarespiratorii ale bolii (0,4%). Majoritatea deceselor prin tuberculoza recidivată se produc în perioada de vârstă de 31-65 de ani (87,2%). Nivelul cel mai înalt al letalităţii la bărbaţi, cât şi la femei s-a înregistrat la grupa de vârstă de 41-65 de ani.

From the existent data about the mortality through recedived pulmonary tuberculosis there were analyzed specific particularities of these in 2015-2017. So, the mortality through tuberculosis recidived and its complications constitution 1,26%000 in 2015, 1,38%000 in 2016 and 1,42%000 in 2017. The mortality determined by the respiratory localization of the tuberculosis is much bigger (99,6%) than the one determined by the extrarespiratory localization of the disease (0,4%). The majority of the deaths through tuberculosis are produced in the period of 31-65 years (87,2%). The peak of the mortality curbe at men is the situated at the group of people at the age of 51-65 years and at women – at the group of people at the age of 41-65 years.

Исходя из имеющихся данных о смертности от рецидивирующего туберкулеза легких, были проанализированы отдельные его особенности в период 2015-2017 гг. Так, смертность от рецидива туберкулеза и его осложнений составила 1,26%000 в 2015 г., 1,38%000в 2016 г. и 1,42%000 в 2017 г. Смертность, обусловленная респираторной локализацией туберкулеза, намного выше (99,6%), чем смертность от туберкулеза. экстрареспираторные локализации заболевания (0,4%). Большинство случаев смерти от рецидивирующего туберкулеза происходит в возрасте от 31 до 65 лет (87,2%). Самый высокий уровень летальности как у мужчин, так и у женщин был зафиксирован в возрастной группе 41-65 лет .

Cuvinte-cheie
tuberculoza, recidivă, mortalitate,

tuberculosis, recurrence, mortality,

туберкулез, рецидив, смертность

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-131344</cfResPublId>
<cfResPublDate>2021-05-31</cfResPublDate>
<cfVol>69</cfVol>
<cfIssue>1</cfIssue>
<cfStartPage>15</cfStartPage>
<cfISSN>1857-0011</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/131344</cfURI>
<cfTitle cfLangCode='RO' cfTrans='o'>Structura letalității prin recidiva tuberculozei pulmonare.</cfTitle>
<cfKeyw cfLangCode='RO' cfTrans='o'>tuberculoza; recidivă; mortalitate; tuberculosis; recurrence; mortality; туберкулез; рецидив; смертность</cfKeyw>
<cfAbstr cfLangCode='RO' cfTrans='o'><p>Din datele existente privind mortalitatea prin tuberculoza pulmonară recidivată s-au analizat anumite particularităţ i ale acesteia în perioada 2015-2017. Astfel, mortalitatea prin tuberculoza recidivată şi complicaţiile ei, a сonstituit 1,26%000 &icirc;n 2015, 1,38%000 &icirc;n 2016 şi 1,42%000 în 2017. Mortalitatea determinată de localizarea respiratorie a tuberculozei este mult mai înaltă (99,6%) decât cea cauzată de localizările extrarespiratorii ale bolii (0,4%). Majoritatea deceselor prin tuberculoza recidivată se produc în perioada de vârstă de 31-65 de ani (87,2%). Nivelul cel mai înalt al letalităţii la bărbaţi, cât şi la femei s-a înregistrat la grupa de vârstă de 41-65 de ani.</p></cfAbstr>
<cfAbstr cfLangCode='EN' cfTrans='o'><p>From the existent data about the mortality through recedived pulmonary tuberculosis there were analyzed specific particularities of these in 2015-2017. So, the mortality through tuberculosis recidived and its complications constitution 1,26%000 in 2015, 1,38%000 in 2016 and 1,42%000 in 2017. The mortality determined by the respiratory localization of the tuberculosis is much bigger (99,6%) than the one determined by the extrarespiratory localization of the disease (0,4%). The majority of the deaths through tuberculosis are produced in the period of 31-65 years (87,2%). The peak of the mortality curbe at men is the situated at the group of people at the age of 51-65 years and at women &ndash; at the group of people at the age of 41-65 years.</p></cfAbstr>
<cfAbstr cfLangCode='RU' cfTrans='o'><p>Исходя из имеющихся данных о смертности от рецидивирующего туберкулеза легких, были проанализированы отдельные его особенности в период 2015-2017 гг. Так, смертность от рецидива туберкулеза и его осложнений составила 1,26%000 в 2015 г., 1,38%000в 2016 г. и 1,42%000 в 2017 г. Смертность, обусловленная респираторной локализацией туберкулеза, намного выше (99,6%), чем смертность от туберкулеза. экстрареспираторные локализации заболевания (0,4%). Большинство случаев смерти от рецидивирующего туберкулеза происходит в возрасте от 31 до 65 лет (87,2%). Самый высокий уровень летальности как у мужчин, так и у женщин был зафиксирован в возрастной группе 41-65 лет .</p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-13539</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-12088</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-16093</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-39323</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-10697</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-13543</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-52105</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-13544</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfFedId>
<cfFedIdId>ibn-doi-131344</cfFedIdId>
<cfFedId>10.52692/1857-0011.2021.1-69.02</cfFedId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
<cfFedId_Class>
<cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId>
<cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId>
</cfFedId_Class>
<cfFedId_Srv>
<cfSrvId>5123451</cfSrvId>
<cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId>
</cfFedId_Srv>
</cfFedId>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-13539</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-13539-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
<cfFamilyNames>Хайдарлы</cfFamilyNames>
<cfFirstNames>И.</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-12088</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-12088-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
<cfFamilyNames>Тудор</cfFamilyNames>
<cfFirstNames>Елена</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-16093</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-16093-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
<cfFamilyNames>Александру</cfFamilyNames>
<cfFirstNames>София</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-39323</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-39323-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
<cfFamilyNames>Râvneac</cfFamilyNames>
<cfFirstNames>Lilia</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-10697</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-10697-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
<cfFamilyNames>Болотникова</cfFamilyNames>
<cfFirstNames>Валентина</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-13543</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-13543-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
<cfFamilyNames>Кула</cfFamilyNames>
<cfFirstNames>Е.</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-52105</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-52105-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
<cfFamilyNames>Guțu-Grecu</cfFamilyNames>
<cfFirstNames>Mariana</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-13544</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-13544-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-05-31T24:00:00</cfStartDate>
<cfFamilyNames>Marusceac</cfFamilyNames>
<cfFirstNames>Irina</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfSrv>
<cfSrvId>5123451</cfSrvId>
<cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName>
<cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr>
<cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw>
</cfSrv>
</CERIF>